Business Standard

Bajaj Healthcare zooms 20%, hits new high on strong June quarter results

Ebitda margin improved to 18.77 per cent from 10.23 per cent in the previous year quarter

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

According to virologists, there are four phases to developing a vaccine.

SI Reporter Mumbai
Shares of Bajaj Healthcare zoomed 20 per cent to a new high of Rs 498.35 on the BSE on Tuesday after the company reported a five-fold jump in net profit at Rs 15.29 crore in the June quarter (Q1FY21), on the back of strong revenue growth. The pharmaceutical company had posted profit of Rs 3.24 crore in the year-ago quarter.

The company’s revenue from operations during the quarter under review grew 52 per cent to Rs 140 crore against Rs 92 crore in the corresponding quarter of previous fiscal. Ebitda (earnings before interest, taxes, depreciation, and amortization) margin improved

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in